Obakiro et al. Tropical Medicine and Health
https://doi.org/10.1186/s41182-020-00256-1
(2020) 48:68
Tropical Medicine
and Health
REVIEW
Open Access
Ethnobotany, ethnopharmacology, and
phytochemistry of traditional medicinal
plants used in the management of
symptoms of tuberculosis in East Africa: a
systematic review
Samuel Baker Obakiro1,2,3* , Ambrose Kiprop2,3 , Isaac Kowino3,4, Elizabeth Kigondu5, Mark Peter Odero2,3 ,
Timothy Omara2,3,6 and Lydia Bunalema7
Abstract
Objective: Many studies on the treatment of tuberculosis (TB) using herbal medicines have been undertaken in
recent decades in East Africa. The details, however, are highly fragmented. The purpose of this study was to provide
a comprehensive overview of the reported medicinal plants used to manage TB symptoms, and to analyze
scientific reports on their effectiveness and safety.
Method: A comprehensive literature search was performed in the major electronic databases regarding medicinal
plants used in the management of TB in East Africa. A total of 44 reports were retrieved, and data were collected
on various aspects of the medicinal plants such as botanical name, family, local names, part(s) used, method of
preparation, efficacy, toxicity, and phytochemistry. The data were summarized into percentages and frequencies
which were presented as tables and graphs.
Results: A total of 195 species of plants belonging to 68 families and 144 genera were identified. Most
encountered species were from Fabaceae (42.6%), Lamiaceae (19.1%), Asteraceae (16.2%), and Euphorbiaceae
(14.7%) families. Only 36 medicinal plants (18.5%) have been screened for antimycobacterial activity. Out of these,
31 (86.1%) were reported to be bioactive with minimum inhibitory concentrations ranging from 47 to 12,500 μg/ml.
Most tested plant extracts were found to have acceptable acute toxicity profiles with cytotoxic concentrations on
normal mammalian cells greater than 200 μg/ml. The most commonly reported phytochemicals were flavonoids,
terpenoids, alkaloids, saponins, cardiac glycosides, and phenols. Only Tetradenia riparia, Warburgia ugandensis, and
Zanthoxylum leprieurii have further undergone isolation and characterization of the pure bioactive compounds.
(Continued on next page)
* Correspondence: sobakiro@gmail.com
1
Department of Pharmacology and Therapeutics, Faculty of Health Sciences,
Busitema University, P.O. Box 1460, Mbale, Uganda
2
Department of Chemistry and Biochemistry, School of Sciences and
Aerospace Studies, Moi University, P.O. Box 3900-30100, Eldoret, Kenya
Full list of author information is available at the end of the article
© The Author(s). 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License,
which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give
appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if
changes were made. The images or other third party material in this article are included in the article's Creative Commons
licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons
licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain
permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
Obakiro et al. Tropical Medicine and Health
Page 2 of 21
(2020) 48:68
(Continued from previous page)
Conclusion: East Africa has a rich diversity of medicinal plants that have been reported to be effective in the
management of symptoms of TB. More validation studies are required to promote the discovery of
antimycobacterial drugs and to provide evidence for standardization of herbal medicine use.
Keywords: Antimycobacterial, Antitubercular, Medicinal plants, Herbal medicine, Phytochemicals, Mycobacterium
tuberculosis
Background
Tuberculosis (TB) is a chronic infectious bacterial disease caused by Mycobacterium tuberculosis (Mtb). It affects mainly the respiratory system but may also affect
other organs of the body causing pulmonary and extrapulmonary TB respectively. The World Health
Organization (WHO) estimated that a quarter of the
world’s population is infected with Mtb and thus at a
risk of developing TB [1]. Although TB affects all people,
those living with HIV/AIDS are at a higher risk of developing active TB [2]. The burden of TB is still high as it
is ranked among the ten diseases of global concern [3].
In 2018, a total of 10 million new cases and 1.49 million
deaths due to TB were reported worldwide. In East Africa, 378,000 new cases and 91,000 deaths (24%) occurred. In East Africa, Kenya and Tanzania are still
ranked among the 30 countries with a high burden of
TB in the world [1].
Treatment of TB remains a challenge due to the
emergence of multidrug-resistant Mtb strains and
extensively drug-resistant TB cases which poorly respond to the first line antitubercular drugs (rifampicin, isoniazid, pyrazinamide, and ethambutol). These
drugs also have side effects and a high potential to
interact with antiretroviral drugs resulting in increased toxicity, poor compliance, and treatment failure [4–6]. As a result, many TB patients have
resorted to using alternative and complementary
medicines with herbal remedies being the most
widely used in the management of tuberculosis [7].
Due to limited access to health services and chronic
poverty in East Africa, many people not only believe
that herbal medicines are efficacious and safe but
also affordable, available, and culturally acceptable
[8–10]. Thus, there is widespread use of herbal remedies by many people in the East Africa to manage
symptoms of TB [7–13]. The WHO also reported
that approximately 60% of the world’s population depend on non-conventional therapies for primary
health care [14].
The search to discover new effective drugs against
Mtb has intensified globally in the last decade as the
current therapies become less effective and in an attempt to have a world free of TB by 2035 [1]. With natural products being the leading sources of novel drugs,
ethnobotanical surveys and scientific validation studies
have been conducted on East African flora in the past
decades [7–10]. Several plant species have been documented and some of their extracts, fractions, and isolated pure compounds have been tested for efficacy and
safety [15–18]. However, this information is highly
fragmented.
Comprehensive data on medicinal plants used in the
management of TB is important for the conservation of
these species as some of them are either rare or endangered. It also provides more evidence that increases the
confidence in the utilization of these herbal remedies for
primary health care as well as their regulation by relevant authorities in case of ineffectiveness and toxicity
[19, 20]. The analysis and synthesis of the results may
also help in identifying existing gaps and challenges in
the current research and stimulates future research opportunities. This can lead to identification of novel molecules that can be developed into new antitubercular
drugs with better efficacy and safety profiles [21]. This
review was therefore undertaken to compile a comprehensive report on the ethnobotany, ethnopharmacology,
and phytochemistry of medicinal plants used in management of symptoms of TB in the East African region so
as to generate knowledge on the current status and future opportunities for drug discovery against TB.
Methods
Reporting and protocol registration
This systematic review was reported according to the
Preferred Reporting Items for the Systematic Reviews
and Meta-Analyses (PRISMA) guidelines [22]. The
protocol used in this study was registered with the International Prospective Register of Systematic Reviews
(PROSPERO) and can be accessed at their website
(https://www.crd.york.ac.uk/prospero/display_record.
php?RecordID=187098) with the registration number
CRD42020187098.
Literature search strategy
Relevant literature pertaining the ethnobotany, phytochemistry, efficacy and safety of medicinal plants utilized
in management of symptoms of TB in Uganda, Kenya,
Tanzania, Rwanda, Burundi and South Sudan were re-
Obakiro et al. Tropical Medicine and Health
Page 3 of 21
(2020) 48:68
trieved from Scopus, Web of Science Core Collection,
PubMed, Science Direct and Google Scholar [23–25].
Key search words such as tuberculosis, mycobacteria, tuberculosis symptoms, tuberculosis treatment, vegetal,
antituberculosis,
antitubercular,
antimycobacterial,
cough, traditional medicine, ethnobotany, alternative
medicine, and ethnopharmacology combined with either
Uganda, Kenya, Tanzania, Rwanda, Burundi, or South
Sudan were used. All publishing years were considered,
and reports in the returned results were carefully scrutinized. More searches were carried out at the Google
search engine using more general search terms, such as
mycobacteria, tuberculosis, antituberculosis, antimycobacterial, cough, vegetal species, vegetal extract, traditional medicine, alternative medicine, plants, plant
extract, vegetal, herbal, complementary therapy, natural
medicine, ethnopharmacology, ethnobotany, herbal
medicine, herb, herbs, decoction, infusion, macerate, and
concoction combined with either Uganda, Kenya,
Tanzania, Rwanda, Burundi, or South Sudan. The
searches were done independently by the authors for
each country and the outputs were saved where possible
on databases and the authors received notifications of
any new searches meeting the search criteria from Science Direct, Scopus, and Google scholar.
Inclusion and exclusion criteria
Only full-text original research articles published in
peer-reviewed journals, books, theses, dissertations, patents, and conference papers on plants used in the management of symptoms of TB in Uganda, Kenya,
Tanzania, Rwanda, Burundi, and South Sudan written in
English and dated until April 2020 were considered.
Study selection
At first, literature screening of the extracted articles
involved examining the titles and abstracts for relevant
articles for inclusion. This was conducted independently
by 6 authors. Then, the full-text articles were evaluated
against the inclusion/exclusion criteria. The article selection process resulted in 44 studies included in this systematic review (Figure S1).
Data collection
A data collection tool was designed in Microsoft Excel
(Microsoft Corporation, USA) to capture data on different aspects of medicinal plant species used in TB management. These included botanical name, plant family,
local name(s), part(s) used, growth habit, mode of preparation and administration, method of extraction, efficacy, toxicity and phytochemical screening of crude
extracts, isolated pure compounds, and efficacy and toxicity. Careful review of the articles was done, and data
were captured using the tool. The collected data were
checked for completeness, processed independently for
each country by the authors and later analyzed.
Data analysis
Missing information in some studies (local names and
growth habit of the plants), and misspelled botanical
names were retrieved from the Google search engine
and botanical databases (The Plant List, International
Plant Names Index, NCBI taxonomy browser, and Tropicos) respectively.
Descriptive statistical methods were used to analyze
the collected data. Results were expressed as ranges, percentages, and frequencies and subsequently presented as
tables and charts. The analyses were performed using
SPSS statistical software (Version 20, IBM Inc.)
Results and discussion
Ethnobotanical studies
With the current antitubercular drugs becoming less
effective in the management of multidrug-resistant Mtb
strains, medicinal plants can provide the novel molecules
for development of new efficacious and safe drugs [26,
27]. From the electronic survey in multidisciplinary databases, 44 reports on medicinal plants used for management of symptoms of TB in East Africa were retrieved.
A total of 195 species of plants belonging to 68 families
and 144 genera were identified (Table 1). Some of these
documented plant species have also been reported in
other regions across the world for management of TB.
For example, Psidium guajava, Catha edulis, Carica papaya, Citrus limon, Lantana camara, Aloe vera, Biden
pilosa, Piliostigma thonningii, Tamarindus indica, Ficus
platyphyla, and Vernonia cinereal in Nigeria, South Africa, Ethiopia, India, and Mexico [60–64]. This implies
that plants continue to occupy a critical niche in the environment due to their rich possession of secondary metabolites (phytochemicals) that have potential to be used
as medicines for several ailments that affect man. Therefore, the use of herbal medicines in the provision of primary health care remains an integral component of all
health systems globally [14].
Most encountered species were from the family Fabaceae
(42.6%), Lamiaceae (19.1%), Asteraceae (16.2%), Euphorbiaceae (14.7%), Moraceae (10.3%), Rubiaceae (10.3%), Rutaceae (8.8%), Burseraceae (7.4%), and Cucurbitaceae (7.4%)
(Fig. 1). Fabaceae, Asteraceae, and Lamiaceae were also reported to provide the largest number of plants species used
for TB management in South Africa, Ghana, Nigeria,
Ethiopia, and India [64–72]. From these families, 15 species
were the most cited in East Africa (Fig. 2). These families
were reported from at least four countries of East Africa.
This could probably be attributed to the abundant distribution of the analogue active substances among species from
these families [23, 24]. The family Fabaceae has biosynthetic
Obakiro et al. Tropical Medicine and Health
Page 4 of 21
(2020) 48:68
Table 1 Medicinal plants used in treatment of symptoms of TB in East Africa
Botanical name
Family
Local Names
Habit
Part used
Country
Author (s)
Acacia ataxacantha DC Fabaceae
Not reported
Tree
Roots
Kenya
[28]
Acacia hockii De Wild.
Fabaceae
Kasana (Luganda), Kashiono
Tree
Leaves, Stem
bark
Uganda
[7, 10]
Acacia horrida (L.)
Fabaceae
Lerai (Samburu)
Tree
Stem bark
Kenya
[29]
Acacia mearnsii De
Wild.
Fabaceae
Burikoti
Tree
Stem bark
Uganda
[10]
Acacia nilotica (L.)
Willd. Ex Delile
Fabaceae
Sunut
Tree
Fruit
South Sudan
[30]
Acacia polyacantha
Willd.
Fabaceae
Egirigirioi
Tree
Stem bark
Uganda
[10]
Acacia senegal
Fabaceae
Lderekesi (Samburu)
Tree
Stem bark
Kenya
[29]
Acacia spectabilis A.
Cunn. Ex Benth.
Fabaceae
Gasiya (Luganda)
Tree
Leaves
Uganda
[7]
Acanthus pubescens
(Thomson ex Oliv.)
Engl.
Acanthaceae
Matovu, Itojo
Herb
Roots
Uganda, Kenya
[10, 12]
Achyranthes aspera L.
Amaranthaceae
Muhurura
Herb
Flower
Uganda
[10]
Achyrospermum
carvalhoi Gürke
Lamiaceae
Kanyamafundo
Shrub
Leaves
Uganda
[10]
Acokanthera friesiorum
Apocynaceae
Chipilikwa (Samburu)
Tree
Leaves
Kenya
[29]
Adenia gummifera
Passifloraceae
Chepnyalildet (Nandi)
Climber Roots
Kenya
[31]
Adhatoda engleriana
Lindau C.B. Clarke
Acanthaceae
Iringoringo (Chagga)
Herb
Tanzania
[32]
Roots
Ageratum conyzoides L. Asteraceae
Namirembe (Luganda)
Herb
Whole plant
Uganda
[7]
Alangium chinense
(Lour.) Harms
Omusiisa (Luganda)
Herb
Stem bark
Uganda
[7]
Cornaceae
Albizia anthelmitica
Fabaceaa
Lamurtana (Samburu)
Tree
Stem bark
Kenya
[29]
Albizia coriaria Welw.
Ex Oliv
Fabaceae
Mugavu (Luganda), Etek
(Lango), Musita (Lusoga),
Omusesa (Runyangkore),
Omubele (Wanga)
Tree
Stem bark
Uganda, Kenya
[7–10, 12,
33]
Albizia species
Fabaceae
Ennongo (Luganda)
Tree
Stem bark
Uganda
[7]
Albizia versicola
Fabaceae
Not reported
Tree
Leaves
Tanzania, Kenya
[12]
Albizia zygia (DC.)
Macbr.
Fabaceae
Ekegonchori (Kuria)
Tree
Roots
Kenya
[12]
Allium sativum L.
Alliaceae
Kitungu saumu (Luo),
Garlic (Luganda)
Herb
Leaves
Uganda, Kenya
[10, 12]
Aloe vera (L.) Burm. f.
Asphodelaceae
Kigaji (Luganda)
Herb
Leaves
Uganda
[7]
Aloe secundiflora Engl.
Aloaceae
Sukuroi (Samburu),
Osukuroi (Masai), Kiluma
(Kamba)
Herb
Leaves
Kenya
[12, 34]
Amaranthus spinosus
Amaranthaceae
Kidodo (Luganda)
Herb
Leaves
Uganda
[10]
Anogeissus leiocarpus
(DC.) Guill. & Perr.
Combretaceae
Sahab
Tree
Stem bark
South Sudan
[30, 35]
Antiaris toxicaria Lesch. Moraceae
Kirundu (Luganda)
Tree
Stem bark
Uganda
[7]
Asparagus africanus
Lam.
Asparagaceae
Mukira gwango (Luganda)
Climber Stem bark
Uganda
[10]
Aspilia africana (Pers.)
C.D. Adams
Asteraceae
Makaayi (Luganda) Emaruoit
Herb
Root bark,
Leaves
Uganda
[7, 10]
Aspilia pluriseta
Schweinf.
Asteraceae
Rirangera
Herb
Roots
Kenya
[28]
Azadirachta indica L.
Meliaceae
Muarubaini (Kamba)
Tree
Seeds
Kenya
[12]
Azadirachta indica A.
Juss.
Meliaceae
Neem tree (Luganda)
Tree
Leaves, stem
bark
Uganda
[7, 10]
Obakiro et al. Tropical Medicine and Health
Page 5 of 21
(2020) 48:68
Table 1 Medicinal plants used in treatment of symptoms of TB in East Africa (Continued)
Botanical name
Family
Local Names
Habit
Part used
Country
Author (s)
Balanites aegyptiaca
(L.) Delile
Zygophyllaceae
Olngosua (Maasai), Ekorete
Shrub
Stem bark
Tanzania, Kenya;
Uganda
[10, 12]
Bersama abyssinica
Fres.
Melianthaceae
Kipsigriet (Sabaot), Kibuimetiet
(Nandi)
Tree
Leaves
Kenya
[36]
Bidens pilosa L.
Asteraceae
Sere, Labika (Luganda), Kalala
(Lusoga), ononot (Lango)
Herb
Flowers,
Leaves
Uganda, Rwanda, [7, 10, 37,
Burundi
38]
Blighia unijugata Baker
Sapindaceae
Enkuza nyana (Luganda)
Tree
Stem bark
Uganda
[7]
Boscia senegalensis
(Pers.) Lam.
Capparaceae
Kursan; Mukheit
Shrub
Not reported
South Sudan
[35]
Bridelia micrantha
(Hochst.) Baill.
Euphorbiaceae
Katazamitti (Luganda), Umugimbu,
Tree
Stem bark,
Root
Uganda, Burundi
[7, 38]
Brillantaisia owariensis
P. Beauv.
Acanthaceae
Icuga
Herb
Leaves
Uganda
[10]
Cadaba farinosa Forssk Capparaceae
Lumuriai (Samburu), Akado
marateng (Luo)
Shrub
Not reported
Kenya
[39]
Callistemon citrinus
(Curtis) Skeels
Myrtaceae
Mwabalabutonya (Luganda)
Shrub
Leaves, Stem
bark
Uganda
[7, 9, 10]
Canarium
schweinfurthii Engl.
Burseraceae
Muwafu (Luganda), Mubafu
(Lusoga, Rutoro)
Tree
Stem bark,
stem, roots
Uganda, Kenya
[7, 9, 12]
Canephora pierre ex A.
Froehner
Rubiaceae
Emwanyi (Luganda)
Shrub
Stem bark
Uganda
[7]
Capparis erythrocarpos
Isert
Capparaceae
Muzingani omwelu, Kitunku
ekitono
Shrub
Roots
Uganda
[10]
Capparis tomentosa
Lam.
Capparaceae
Muzingani omwelu, Kitunku
ekitono
Shrub
Roots
Uganda
[10]
Carica papaya L.
Caricaceae
Amapapali, Paapali essajja
(Luganda), Mupapali omusaiza
(Lusoga), Apapalu (Lango)
Shrub
Leaves, Stem
Uganda
[7, 9, 10]
Carissa edulis (Forsk.)
Vahl
Apocynaceae
Muyonza, Ekamuriei (Ateso)
Shrub
Roots
Uganda
[10]
Cassine buchananii
Loes.
Celastraceae
Mbaluka (Luganda)
Tree
Stem bark,
Leaves
Uganda
[8]
Catha edulis Forsk.
Celastraceae
Chemgangoi (Sabaot)
Shrub
Stem bark
Kenya
[36]
Celosia trigyna L.
Amaranthaceae
Kakubaggiri (Luganda)
Herb
Leaves
Uganda
[7]
Chaetacme aristata
Planch.
Ulmaceae
Embutami (Luganda)
Tree
Leaves
Uganda
[7]
Cinnamomum
zeylanicum Blume
Lauraceae
Mudalasini (Luganda)
Tree
Stem bark
Uganda
[7]
Cissampelos pereira L.
Menispermaceae
Karigi munana
Liana
Roots
Kenya
[28]
Cissus quinquangularis
L.
Vitaceae
Sukurtuti
Herb
Roots
Kenya
[12, 34]
Citrus limon (L.) Osbeck Rutaceae
Nimawa
Tree
Fruit
Uganda
[9]
Combretum molle R.Br.
ex. G. Don.
Combretaceae
Ndagi, Loro (Lango)
Tree
Stem bark
Uganda
[7, 8, 10]
Commiphora species
Burseraceae
Oltemuai (Sabaot)
Shrub
Not reported
Kenya
[40]
Commiphora edulis
(Klotzsch)
Burseraceae
Not reported
Shrub
Stem bark,
Leaves
Kenya
[12, 26]
Commiphora ellenbeckii Burseraceae
Engl.
Not reported
Shrub
Stem bark,
Leaves
Kenya
[26]
Commiphora
mildbraedii Engl.
Burseraceae
Not reported
Shrub
Stem bark,
Root bark
Kenya
[26]
Cordia africana Lam
Boraginaceae
Not reported
Tree
Roots
Tanzania, Kenya
[12]
Crassocephalum
vitellinum
Apiaceae
Akayungubira
Herb
Leaves
Burundi
[38]
Crossopteryx febrifuga
Rubiaceae
Not reported
Tree
Roots
Tanzania, Kenya
[12]
Obakiro et al. Tropical Medicine and Health
Page 6 of 21
(2020) 48:68
Table 1 Medicinal plants used in treatment of symptoms of TB in East Africa (Continued)
Botanical name
Family
Local Names
Habit
Part used
Country
Author (s)
Croton dichogamus
Pax.
Euphorbiaceae
Oloiborrbenek (Massai)
Shrub
Roots
Tanzania, Kenya
[12]
Croton macrostachyus
Hochst. ex Del
Euphorbiaceae
Omutswitswi (Wanga), Mukinduri (Kikuyu)
Tree
Leaves, Roots
Kenya
[33]
Croton sylvaticus
Euphorbiaceae
Not reported
Tree
Roots
Tanzania
[41]
Croton zambesicus
Euphorbiaceae
Um-Gilagla
Tree
Fruit
South Sudan
[42, 43]
Cryptolepis
sanguinolenta
Apocynaceae
Kafulu (Luganda)
Shrub
Roots
Kenya, Uganda
[12, 44]
Cymbopogon citratus
D.C. ex Stapf
Poaceae
Kisubi (Luganda), Akisube (Ateso), Lum cai (Lango)
Herb
Leaves
Uganda
[7]
(Afzel. ex G.Don)
Benth.
Cyperus latifolius Poir.
Cyperasaceae
Ekekeriaut
Herb
Roots
Uganda
[10]
Cyperus rotundus L.
Subsp. rotundus
Cyperasaceae
Ekekeriaut
Herb
Roots
Uganda
[10]
Cyphostemma
adenocaule
Vitaceae
Lordo (Samburu)
Herb
Not reported
Kenya
[34]
Dalbergia melanoxylon
Guill. & Perr.
Fabaceae
Not reported
Tree
Stem bark
Kenya
[28]
Datura stramonium
Solanaceae
Not reported
Herb
Leaves
Rwanda
[45]
Desmodium salicifolium Fabaceae
(Poir.) D.C.
Enkolimbo (Luganda)
Herb
Leaves
Uganda
[7]
Desmodium repandum
(Vahl) DC.
Papilionaceae
Ituza
Herb
Leaves
Uganda
[10]
Dichrostachys cinerea
(L.) Wight and Arn
Fabaceae
Chinjiri (Digo)
Tree
Roots
Kenya
[28]
Dodonaea angustifolia
L. f.
Sapindaceae
Musambya (Luganda)
Shrub
Leaves
Uganda
[10]
Dracaena steudneri
Engl.
Asparagaceae
Kajjolyenjovu (Luganda)
Tree
Stem bark
Uganda, Kenya
[7, 9, 10,
12]
Dychrostachys
glomerata (DG)
(Forssk.)
Fabaceae
Not reported
Tree
Leaves, Roots
Uganda, Kenya,
Tanzania
[10, 12,
29]
Embelia schimperi
Vatke
Myrsinaceae
Sachuonet (Ogiek)
Tree
Stem bark
Kenya
[46]
Entada abbysinica A.
Rich.
Fabaceae
Laginaria (Luo) Mwolola (Luganda)
Shrub
Roots, Stem
bark, Leaves
Uganda, Kenya,
Tanzania
[7, 10, 12,
29]
Erythrina abyssinica
Lam. ex DC.
Fabaceae
Ejjirikiti (Luganda), Kiko Omoko (Rutoro), Oluo (Lugbara),
Owila kot (Lango), Muyirikiti (Lusoga), Omotembe
(Kisii)Muhuti (Kikuyu), Umurinzi
Tree
Stem bark,
leaves
Uganda, Kenya,
Tanzania,
Rwanda, Burundi
[7–10, 12,
38, 45,
47]
Eucalyptus species
Myrtaceae
Kalintusi (Luganda)
Tree
Leaves, Stem
bark
Uganda, Kenya,
[7–10, 12,
Tanzania, Rwanda 47, 48]
Euclea divinorum Hiern
Ebenaceae
Emus, Kasalagala/Muda (Lusoga)
Shrub
Roots
Uganda
[10]
Euphorbia ingens
E.Mey. ex Boiss.
Euphorbiaceae
Not reported
Tree
Roots
Kenya
[28]
Euphorbia
schimperiana Scheele
Euphorbiaceae
Kazagamira (Luganda)
Tree
Leaves
Uganda
[7]
Faidherbia albida (Del.)
Chevi.
Fabaceae
Haraz
Tree
Leaves
South Sudan
[42]
Ficus glumosa Delile
Moraceae
Muwo (Luganda)
Shrub
Stem bark
Uganda
[7]
Ficus natalensis Hochst. Moraceae
Omutuba (Luganda), Mugaire (Lusoga)
Tree
Stem bark
Uganda
[7]
Ficus platyphylla Delile
Moraceae
Mudodwe
Shrub
Stem bark
Uganda
[10]
Ficus saussureana
Moraceae
Omuwo (Luganda)
Shrub
Stem bark
Uganda
[8]
Fleurya aestuans (L.)
Gaudich. ex Miq.
Urticaceae
Munyango (Luganda)
Herb
Leaves
Uganda
[7]
Obakiro et al. Tropical Medicine and Health
Page 7 of 21
(2020) 48:68
Table 1 Medicinal plants used in treatment of symptoms of TB in East Africa (Continued)
Botanical name
Family
Local Names
Habit
Part used
Country
Author (s)
Garcinia buchananii
Baker
Clusiaceae
Musaali (Luganda)
Tree
Stem bark,
Root bark
Uganda, Kenya,
Tanzania
[7, 10, 12]
Gnaphalium
purpureum L.
Asteraceae
Omuya (Luganda)
Herb
Leaves
Uganda
[7]
Gnidia buchananii Gilg
Thymelaeaceae
Not reported
Herb
Roots
Kenya
[49]
Gomphocarpus
physocarpus E. Mey.
Apocynaceae
Gashaho
Herb
Leaves
Uganda
[10]
Gutenbergia cordifolia
Benth. ex Oliv.
Asteraceae
Ekoutapem
Herb
Roots, Leaves
Uganda
[10]
Harrisonia abyssinica
Oliv.
Simaroubaceae
Mutagataga (Meru), Osiro (Luo), Orongoriwe (Kuria),
Lushaike
Shrub
Stem bark
Uganda, Kenya
[10, 50,
51]
Harungana
madagascariensis
Lam.ex Pior
Hypericaceae
Mukabiiransiko (Luganda)
Tree
Stem bark,
Leaves
Uganda
[8]
Helichrysum
odoratissimum (L.)
Asteraceae
Lweza (luganda)
Herb
Leaves
Uganda
[10]
Heterotis canescens
Melastomataceae
Umusomaw’a-bungere,
Herb
Leaves
Burundi
[38]
Hibiscus fuscus Garcke
Malvaceae
Lusaala (Luganda)
Herb
Leaves
Uganda
[7]
Hoslundia opposita
Vahl
Lamiaceae
Cheroronit, Cherungut (Nandi), Nfodo (Lusoga)
Shrub
Leaves
Uganda, Kenya
[10, 31]
Hypericum revolutum
Vahl
Clusiaceae
Mushungwa
Tree
Leaves
Uganda
[10]
Hypoestes verticillaris
(L.f.) Sol.
Acanthaceae
Narubat (Ogiek)
Herb
Roots
Kenya
[46]
Iboza multiflora
(Benth.) E. A. Bruce
Lamiaceae
Iseja
Shrub
Leaves
Uganda
[10]
Iboza riparia (Hochst.)
N. E. Br.
Lamiaceae
Muravumba
Shrub
Leaves
Uganda
[10]
Indigofera emarginella
Steud. ex A. Rich.
Fabaceae
Olutunga nsonzi (Luganda)
Shrub
Leaves, Stem
bark
Uganda
[7]
Indigofera lupatana
Baker F
Fabaceae
Not reported
Shrub
Roots
Kenya
[28]
Kalanchoe glaucescens
Planch. ex Benth
Crassulaceae
Ekiyondo ekyeru (Luganda)
Herb
Leaves
Uganda
[7, 9]
Kalanchoe integra
Crassulaceae
Not reported
Shrub
Leaves
Rwanda
[48]
Khaya senegalensis
Meliaceae
Not reported
Tree
Leaves, Stem
bark
South Sudan
[52]
Lagenaria sphaerica
(Sond.) Naudin
Cucurbitaceae
Mutanga
Herb
Leaves
Uganda
[10]
Lantana camara L.
Verbenaceae
Kayukiyuki (Luganda), Owinybilo (Lango), Kanpanga
(Ateso)
Shrub
Leaves
Uganda
[7, 10, 53]
Lantana trifolia
Verbenaceae
Not reported
Shrub
Leaves
Rwanda
[48]
Leonotis nepetifolia (L.)
R. Br.
Lamiaceae
Susuni
Shrub
Leaves
Uganda
[10]
Leucas calostachys Oliv. Lamiaceae
Kakuba musulo (Luganda)
Shrub
Leaves, Whole Uganda
plant
[8]
Lippia grandifolia
Hochst. ex A. Rich
Verbenaceae
Olugumaguma (Luganda)
Herb
Leaves
Uganda
[7]
Lonchocarpus eriocalyx
Harms
Fabaceae
Not reported
Tree
Stem bark
Kenya
[11, 28]
Maesa lanceolata
Forssk.
Myrsinaceae
Muhanga
Tree
Roots
Uganda
[10]
Mangifera indica L.
Anacardiaceae
Muyembe (Luganda), Aeme (Lango)
Tree
Stem bark
Uganda, Kenya
[7, 9, 10,
12, 47]
Maytenus senegalensis
Celastraceae
Naligwalimu (Luganda), Muwaiswa, Eterka, Itereka
Shrub
Root bark,
Uganda
[7, 10]
Obakiro et al. Tropical Medicine and Health
Page 8 of 21
(2020) 48:68
Table 1 Medicinal plants used in treatment of symptoms of TB in East Africa (Continued)
Botanical name
Family
(Lam.)
Local Names
Habit
(Lango)
Part used
Country
Author (s)
Leaves
Microglossa pyrifolia
(Lam.)
Asteraceae
Kabilili akatono (Luganda)
Shrub
Roots
Uganda
[10]
Microgramma
lycopodiodes (L.) Copel
Polypodiaceae
Kukumba (Luganda)
Herb
Roots, Leaves
Uganda
[8]
Milicia excelsa (Welw.)
C.C. Berg
Moraceae
Muvule (Luganda)
Tree
Leaves
Uganda
[7]
Momordica foetida
Schumach.
Cucurbitaceae
Bombo (Luganda), Luiwula/Mwishwa
Herb
Leaves
Uganda, Rwanda
[7, 10, 45]
Momordica rostrata A.
Zimm.
Cucurbitaceae
Chepkologolio (Ogiek)
Herb
Roots
Kenya
[46]
Morella kandtiana
(Engl.) Verdc. & Polhill
Myricaceae
Mukikimbo (Luganda)
Herb
Roots, Leaves, Uganda
Whole plant
[8]
Morinda lucida Benth.
Rubiaceae
Kabaja nsayi (Luganda)
Tree
Stem bark
Uganda
[7]
Moringa oleifera Lam.
Moringaceae
Moringa (Luganda)
Tree
Fruit, Stem
Uganda
[7, 10]
Mucuna pruriens (L.)
DC.
Papilionaceae
Lugenyu (Luganda)
Vine
Leaves
Uganda
[10]
Myrica kandtiana Engl.
Myricaceae
Enkikimbo(Luganda)
Tree
Fruit, Leaves,
Stem bark,
Root bark
Uganda
[7]
Myrsine africana L.
Myrsinaceae
Seketeti (Samburu)
Shrub
Not reported
Kenya
[34]
Nauclea latifolia Sm
Rubiaceae
Karmadoda
Tree
Fruit
South Sudan
[54]
Ocimum basilicum
Lamiaceae
Umusurasura
Herb
Leaves
Burundi
[38]
Ocimum suave Willd.
Lamiaceae
Muhumuzanganda (Luganda)
Herb
Leaves
Uganda
[10]
Olea capensis L.
Oleaceae
Pekeriondet (Sabaot)
Tree
Stem bark
Kenya
[36]
Olinia rochetiana
Penaeaceae
Kaptolongit (Sabaot)
Tree
Roots
Kenya
[36]
Ormocarpum
trichocarpum (Taub.)
Harms
Papilionaceae
Eseperuae
Tree
Roots
Uganda
[10]
Pappea capensis
(Spreng) Eckl. & Zeyh.
Sapindaceae
Muba (Kikuyu), Enkorrirri, Oltimigomi (Maasai)
Shrub
Stem bark,
Root bark
Kenya
[55, 56]
Parinari curatellifolia
Planch. ex Benth.
Chrysobalanaceae Umunazi
Tree
Stem bark,
roots
Burundi
[38]
Pavetta crassipes K.
Schum.
Rubiaceae
Not reported
Shrub
Roots
Tanzania, Kenya
[12]
Pentas longiflora Oliv.
Rubiaceae
lsagara
Herb
Roots
Rwanda
[37]
Persea americana Mill.
Lauraceae
Ovacado (Luganda)
Tree
Stem bark
Uganda
[7, 9]
Phaseolus lunatus L.
Fabaceae
Kayindiyindi (Luganda)
Herb
Leaves
Uganda
[7]
Phaseolus vulgaris L.
Fabaceae
Bijanjaro (Luganda)
Herb
Husks
Uganda
[7]
Phyllanthus reticulatus
Poir.
Phyllanthaceae
Mutulika (Luganda)
Shrub
Leaves
Uganda
[7]
Piliostigma thonningii
Fabaceae
Chebutiandet (Sabaot)
Tree
Leaves
Kenya
[36]
Piptadenistrum africana Fabaceae
Mpewere (Luganda)
Tree
Stem bark
Uganda
[7, 9, 10]
Plectranthus barbatus
Andrews
Lamiaceae
Ekibankulata (Luganda), Ebiriri omutano (Ateso)
Shrub
Leaves
Uganda
[7, 10]
Plectranthus hadiensis
Lamiaceae
Kibwankulanta (Luganda)
Shrub
Whole plant,
Leaves
Uganda
[8]
Plumbago dawei
Plumbaginaceae
Lkiarianthus (Samburu)
Herb
Stem bark
Kenya
[29]
Plumbago zeylanica L.
Plumbaginaceae
Musajjabanda (Luganda), Mukya (Kamba)
Herb
Leaves
Uganda, Kenya
[7, 34, 57]
Podocarpus
usambarensis Pilg.
Podocarpaceae
Kamusenene (Luganda)
Tree
Leaves
Uganda
[7]
Prunus africana
(Hook.f.) Kalkman
Rosaceae
Ntaseesa, Ngwabuzito (Luganda, Rutoro),Sirumandu
(Lugisu)
Tree
Stem bark
Uganda
[7]
Obakiro et al. Tropical Medicine and Health
Page 9 of 21
(2020) 48:68
Table 1 Medicinal plants used in treatment of symptoms of TB in East Africa (Continued)
Botanical name
Family
Local Names
Habit
Part used
Country
Author (s)
Pseudospondia
microcarpa (A. Rich.)
Engl.
Anacardiaceae
Muziru (Luganda)
Tree
Stem bark
Uganda
[7]
Psidium guajava L.
Myrtaceae
Mpera (Chagga)
Tree
Fruit, Leaves,
Stem bark,
Root bark
Uganda, Kenya,
Tanzania
[7, 12]
Pycnostachys ericirosenii Lamiaceae
R.E.Fr.
Musindikwa (Luganda)
Shrub
Leaves
Uganda
[10]
Rhamnus prinoides
L’Herit.
Rhamnaceae
Munanira (Luganda)
Shrub
Leaves
Uganda
[10]
Rhoicissus tridentata
(L.f.) Wild. & R.B.D.
Drumm.
Vitaceae
Mumara (Luganda)
Shrub
Leaves
Uganda
[10]
Rhus natalensis Bernh.
ex Krauss
Anacardiaceae
Lmisigiyoi, Muthigiu (Kikuyu)
Tree
Roots, Leaves
Kenya
[51]
Rhus vulgaris Meikle
Anacardiaceae
Kakwansokwanso (Luganda)
Herb
Stem bark,
Leaves
Uganda
[7]
Ribes uva-crispa L.
Grossulariaceae
Entuntunu (Luganda)
Shrub
Leaves
Uganda
[7]
Rosmarinus officinalis L. Lamiaceae
Not reported
Herb
Leaves
South Sudan
[52]
Rubia cordifolia L.
Rubiaceae
Kasalabakesi (Luganda) Urumurwa (Kuria)
Herb
Leaves, Whole Uganda, Kenya,
plant
Tanzania
[7, 9, 10,
12, 16]
Rumex abyssinicus
Jacq.
Polygonaceae
Not reported
Herb
Leaves
Rwanda
[48]
Sapium ellipticum
(Hochst.) Pax
Euphorbiaceae
Omusasa (Luganda)
Shrub
Stem bark
Uganda
[7]
Securidaca
longipedunculata
Fresen.
Polygalaceae
Mukondwa, Awee ilila (Lango), Mukondwa (Lusoga),
Eliloi (Ateso)
Tree
Roots
Uganda
[8, 10]
Senna siamea (Lam.)
Irwin & Barneby
Fabaceae
Gasiya seed
Tree
Stem bark
Uganda
[10]
Sesamum calycinum
Pedaliaceae
Lutungotungo (Luganda)
Herb
Leaves, Whole Uganda
plant
[8]
Solanum aculeastrum
Dunal
Solanaceae
Mutura (Kikuyu), Ekitengo (Luganda)
Shrub
Fruit, Roots,
Leaves
Uganda, Kenya
[7, 8, 12]
Solanum incanum L.
Solanaceae
Entengotengo Ennene (Luganda), Ocokocok (Lango),
Ntonka (Lusoga), Mutongu (Kamba),Entulelei (Maasai)
Shrub
Fruit
Uganda, Kenya
[7, 12]
Solanum mauense
Bitter
Solanaceae
Ng’onyoyiek (Ogiek)
Shrub
Seeds
Kenya
[46]
Spathodea
campanulata P. Beauv.
Bignoniaceae
Kifabakazi (Luganda)
Tree
Stem bark
Uganda
[7]
Syzygium cumini (L.)
Skeels
Myrtaceae
Jambula (Luganda)
Tree
Stem bark
Uganda
[7, 9]
Tamarindus indica L.
Fabaceae
Mukoge (Luganda), Cwao (Lango)
Tree
Leaves
Uganda
[10]
Teclea nobilis Del.
Rutaceae
Luzo
Shrub
Leaves
Uganda
[10]
Tetradenia riparia
(Hochst.) Codd
Lamiaceae
Ekyewamala (Luganda)
Herb
Leaves
Uganda, Rwanda
[7, 37]
Terminalia laxiflora
Engl. & Diels
Combretaceae
Darout
Tree
Stem bark
South Sudan
[30]
Tithonia diversifolia
(Hemsl.) A. Gray
Asteraceae
Ekimyula, Okelokelo (Lango)
Shrub
Stem bark
Uganda
[7]
Toddalia asiatica (L.)
Lam
Rutaceae
Simborichet (Sabaot), Mururue (Kikuyu), Oleparmunyo
(Maasai), Kawule (Luganda)
Shrub
Roots, Leaves
Uganda, Kenya
[7, 8, 10,
36]
Tragia brevipes Pax
Euphorbiaceae
Nakepian
Climber Roots
Uganda
[10]
Tragia subsessilis Pax
Euphorbiaceae
Totoananyia
Herb
Roots
Uganda
[10]
Trichilia dregeana
Sond.
Meliaceae
Sekoba (Luganda)
Tree
Stem bark,
Uganda
[7]
Obakiro et al. Tropical Medicine and Health
Page 10 of 21
(2020) 48:68
Table 1 Medicinal plants used in treatment of symptoms of TB in East Africa (Continued)
Botanical name
Family
Local Names
Habit
Part used
Country
Author (s)
Triumfetta flavescens
Hochst. ex A. Rich.
Malvaceae
Luwugula (Luganda)
Shrub
Stem
Uganda
[7]
Vachellia
drepanolobium (Harms
ex Sjostedt) P.J.H.
Huter
Fabaceae
Oluai (Maasai)
Tree
Stem bark,
Root bark
Kenya
[55]
Vernonia cinerea (L.)
Less.
Asteraceae
Kayayana, Lukohe (Luganda), Yat Kwong
(Lango)
Herb
Leaves
Uganda
[7]
Vernonia amygdalina
Del.
Asteraceae
Mululuza (Luganda) Lubilili
Shrub
Leaves
Uganda
[7, 10]
Warburgia ugandensis
Sprague
Canellaceae
Abaki, Sokoni (Samburu), Muthiga
(Kikuyu)
Tree
Stem bark
Uganda, Kenya,
Tanzania
[7–10, 12,
16, 57–
59]
Zanthoxylum
chalybeum Engl.
Rutaceae
Ntale ya ddungu (Luganda), Eusuk (Ateso),
Agodaman (Lango), Oloisuki (Maasai),
Rukuts (Karimojong), Outiku (Lugbara)
Tree
Stem bark
Uganda, Kenya,
Tanzania
[5, 8–10,
12]
Zanthoxylum gillettii
(De Wild.) P.G.
Waterman
Rutaceae
Sagawatiet, Shihumba/Shikuma
Tree
Stem bark
Kenya
[31]
[5]
Zanthoxylum leprieurii
Rutaceae
Not reported
Tree
Stem bark
Uganda
Zehneria scabra
Cucurbitaceae
Umushishiro,
Herb
Leaves
Burundi
[38]
Zingiber officinale
Zingiberaceae
Tangawizi (Luo), Ntangawuzi (Luganda)
Herb
Stem
Uganda, Kenya
[7, 9, 10,
12]
Languages: Ateso, Lango, Luganda, Lugbara, Lugisu, Lusoga, Karimojong, and Rutoro (Uganda); Digo, Kamba, Kikuyu, Kisii, Kuria, Luo, Maasai, Meru,
Nandi, Ogiek ,Sabaot, Samburu, and Wanga (Kenya); and Chagga (Tanzania). Local names with language(s) not indicated were not specified by
the authors
pathways that produce majorly flavonoids, terpenoids, and
alkaloids as secondary metabolites [73–75]. It is these phytochemicals that are responsible for the antimycobacterial
activity against different mycobacterial strains [67, 70, 76,
77]. Other families reported in East Africa to house medicinal plants for management of TB and have also been
reported in other countries include Acanthaceae, Apocynaceae, Cariaceae, Combretaceae, Malvaceae, Moraceae, Myrtaceae, Rhamnaceae, Rubiaceae, Solanaceae, and
Zingiberaceae [64, 72, 78–81].
Geographically, none of the documented plant species
was reported to be used in the management of TB
across all the East African countries. However, two plant
species (Erythrina abyssinica and Eucalyptus species) are
used by at least 4 countries. A total of 30 plant species
were reported to be used by at least two countries.
Uganda had the highest number of species mentioned
followed by Kenya and then Tanzania (Table 1). The differences in species utilization could be attributed to the
differences in soil chemistry, rainfall, topography, and
climate that results into differences in phytochemical
composition of the same species growing in different
geographical areas [82]. Additionally, it could also be
due to differences in knowledge and experiences as result of different social and cultural backgrounds that exists across the countries. Uganda had many
ethnobotanical surveys conducted to document medicinal plants used in the management of tuberculosis as
compared to other countries. Most of these medicinal
plants were growing as trees (40.0%), herbs (29.7%),
shrubs (27.7%), and rarely as climbers, vines, or lianas
(Fig. 3).
Analysis of ethnomedicinal recipes revealed that
mainly leaves (38.6%), stem bark (28.4%), and roots
(18.6%) were used for preparing herbal remedies. Root
bark, whole plants, fruits, flowers, seeds, and husks were
rarely used (Fig. 4). Harvesting of leaves and stem bark
allows sustainable utilization of the plants hence promoting their conservation as opposed to use of roots
and whole plants. Additionally, leaves are the primary
sites for secondary metabolic pathways in plants while
stem barks act as major concentration areas (deposition
sites) for the synthesized metabolites [9, 57].
Most articles reviewed reported that traditional herbal
medicine practitioners usually combined different plant
species while preparing herbal medicines. However, they
did not report how the herbal medicine from individual
plant species can be prepared. Decoction was by far the
commonest method of herbal medicine preparation
cited. Others included cold infusions, drying and pounding into a powder, burning into ash, chewing, and
steaming. Use of more than one plant in combination is
more effective than single plant perhaps due to the synergistic interactions that occur among the different phytochemicals that result into increased bioactivity
(efficacy). But also, the benefit of phytochemicals from
Obakiro et al. Tropical Medicine and Health
Page 11 of 21
(2020) 48:68
Fig. 1 Major botanical families from which TB remedies are obtained in East Africa
one species counteracting the toxicity of another species
could be another explanation.
The major route of administration was oral (via the
mouth) although sometimes inhalation and topical application were also reported depending on the preparation
method used and the toxicity of the plant(s). Cups, bottles, and tablespoons were the most commonly used for
determining the posology of herbal remedies [7, 10, 12].
Efficacy and safety studies
Some ethnobotanical studies reported that herbal medicine preparations were effective in the treatment of TB,
while some were used in the management of multidrugresistant tuberculosis [7, 12, 47]. This could be due to
the synergistic interaction between the various
phytochemicals present in the herbal preparations [27,
83]. However, as much as these herbal medicines might
have genuine bioactivity, sometimes they are used concurrently with conventional therapies as supplements
and at times adulterated. Therefore, it is important to
scientifically validate the claimed efficacy and safety of
both the herbal preparations and the individual medicinal plants. Out of the 195 species documented, only 36
plant species (18.5%) have been studied for their antimycobacterial activity. A WHO report [14] indicated that
only approximately 10% of the world’s flora have been
studied as regards their medicinal potential. This has
greatly hindered the discovery of potential lead compounds that could be developed into new antitubercular
drugs.
Obakiro et al. Tropical Medicine and Health
(2020) 48:68
Fig. 2 The most cited plant species used for treatment of TB and its symptoms in East Africa
Fig. 3 Growth habit of the plants used for preparation of antitubercular remedies in East Africa
Page 12 of 21
Obakiro et al. Tropical Medicine and Health
Page 13 of 21
(2020) 48:68
Fig. 4 Frequency of plant parts used for preparation of antitubercular remedies in East Africa
Out of the 36 screened medicinal plants, 31 species
(86.1%) were reported to be bioactive with some species
exhibiting quite considerable antimycobacterial activity
although the current standard drugs had superior bioactivity (Table 2). This is comparable to India where
70% of 365 plants which were studied showed antimycobacterial activity [87]. Among the promising plant species (with minimum inhibitory concentration less than
0.5 mg/ml) were Erythrina abyssinica, Entada abyssinica,
Bidens pilosa, Callistemon citrinus, Khaya senegalensis,
Lantana camara, Piptadenistrum africana, Rosmarinus
officinalis, Tetradenia riparia, and Zanthoxylum
leprieurii. Isolated pure compounds from three of the
promising plant species had much higher activity against
Mtb than the crude extracts and fractions. Indeed, some
of the compounds from Zanthoxylum leprieurii had
minimum inhibitory concentrations lower than those of
standard antitubercular drugs (Table 3). Crude extracts
and fractions usually have less pharmacological activity
than standard drugs because of the interference from
other inactive substances in the matrix that reduce the
overall concentration of the active molecules in the
tested dose. This explains why isolation of pure compounds is a critical step in natural product drug discovery process. The five documented medicinal plants that
were found to be inactive are Acacia ataxacantha, Dalbergia melanoxylon, Indigofera lupatana, Lonchocarpus
eriocalyx, and Solanum incanum. This could probably
be attributed to the absence of inherent bioactive phytochemicals against Mtb in the plant species. This could
be brought about by absence or impaired biosynthetic
metabolic pathways due to unfavorable growth conditions in the habitat from where the plants grow. This
implies that herbal remedies for TB containing each of
these plants singly may not be effective. Therefore, other
benefits provided by these species in the concoctions of
TB such as detoxification of other toxic phytochemicals,
preservation of the herbal medicine, or potentiation of
the pharmacological activity of other phytochemicals
could be investigated.
All toxicity studies reviewed evaluated only the acute
toxicity profiles of the medicinal plants either in vitro or
in vivo but not both. Of the bioactive extracts screened,
less than half of them were tested for their acute toxicity.
Selectivity index (SI) is used as the best estimate of the
relative toxicity of a compound to normal mammalian
cells as compared to the pathogen and hence its suitability for being a drug candidate. According to the SI criterion, compounds with higher SI are regarded to have
better toxicity profiles than those with lower SI [88].
From the retrieved data, only two plant species (Khaya
senegalensis and Rosmarinus officinalis) had acceptable
selectivity indices to warrant drug discovery from them.
In this study, the SI of only five plant species could be
Obakiro et al. Tropical Medicine and Health
Page 14 of 21
(2020) 48:68
Table 2 Efficacy, toxicity, and phytochemical studies on medicinal plants used for treatment of TB in East Africa
Plant
Extraction method MIC (μg/ml) on
(solvent)
H37Rv strain
MIC (μg/ml) on
TMC-331 strain
Toxicity of crude
extracts (μg/ml)
Class of compounds
Author(s)
Acacia
ataxacantha
Maceration
(methanol)
Not tested
IC50 = 90.39
Phenols, terpenoids
[28]
Acacia horrida
Soxhlet (methanol) < 1000 (Iso < 500)
Not tested
Not tested
Alkaloids, cardiac
glycosides, tannins,
saponins, terpenoids
[29]
Acacia senegal
Soxhlet (methanol) < 1000 (Iso < 500)
Not tested
Not tested
Cardiac glycosides,
tannins, saponins,
terpenoids, flavonoids
[29]
Acokanthera
friesiorum
Soxhlet (methanol) < 1000 (Iso < 500)
Not tested
Not tested
Cardiac glycosides,
Tannins, flavonoids
[29]
Albizia
anthelmitica
Soxhlet (methanol) < 1000 (Iso < 500)
Not tested
Not tested
Alkaloids, saponins,
tannins, flavonoids
[29]
Not active
Aspilia pluriseta Maceration
(methanol)
Active at 1 g/ml (MIC not
determined)
Not tested
IC50 = 24.51
Phenol, terpenoids,
flavonoids
[28]
Bidens pilosa
Maceration
(ethanol)
100
Not tested
Not tested
Not tested
[37]
Callistemon
citrinus
Maceration
(methanol,
chloroform)
325 (methanol), 48 (chloroform) 78 (methanol), 158
(Iso = 4.0; R = 2.0)
(chloroform), Iso =
4.0
Not tested
Flavonoids, alkaloids,
triterpenoids, saponins
[15]
Cissampelos
pareira
Maceration
(methanol)
Active at 1 g/ml (MIC not
determined)
Not tested
IC50 = 179
Anthraquinones, phenols, [28]
terpenoids, flavonoids
Commiphora
edulis
Maceration (ethyl
acetate, DCM,
water)
6250 (Ethyl acetate), 780
(methanol), Not active (water)
Not tested
IC50 = 393 (DCM), Flavonoids, terpenoids
1734 (ethyl
acetate)
[26]
Commiphora
ellenbeckii
Maceration (ethyl 12500 (Ethyl acetate), 3125
acetate, methanol, (methanol), 780 (water), 15 (rif)
water)
Not tested
IC50 = 608
(methanol), 1509
(water)
Alkaloids, saponins,
tannins, phenols,
flavonoids, terpenoids
[26]
Commiphora
mildbraedii
Maceration (ethyl 6250–9250 (Ethyl acetate), 390– Not tested
acetate, methanol, 780 (methanol), not active
water)
(water), 15 (Rif)
IC50 = 339 (ethyl
acetate), 452
(methanol)
Alkaloids, saponins,
tannins, phenols,
flavonoids, terpenoids
[26]
Cordia sinensis
Soxhlet (methanol) < 500 (Iso < 500)
Not tested
Not tested
Saponins, terpenoids,
flavonoids, tannins
[29]
Cryptolepsis
sanguinolenta
Methanol
chloroform
1170 (methanol) (Iso = 0.25; R
= 0.25)
1580 (methanol)
(Iso = 0.25)
LD50 = 758 mg/
kg
Alkaloids, tannins,
flavonoids
[84]
Dalbergia
melanoxylon
Maceration
(methanol)
Not active
Not tested
IC50 = 120.04
Phenols, terpenoids
[28]
Dichrostachys
cinerea
Maceration
(methanol)
Active at 1 g/ml, (MIC not
determined)
Not tested
IC50 = 201.22
Phenols, terpenoids
[28]
Entadda
abyssinica
Maceration
(methanol)
500 (Iso = 0.25)
Not tested
Not tested
Flavonoid, alkaloids,
saponins, tannins
[12, 29]
Erythrina
abyssinica
Maceration
(methanol)
390 (Rif = 0.25; Iso = 0.25)
2350 (Iso = 9.38)
LD50 = 776.2 mg/ Flavonoids, alkaloids,
tannins
kg
[44]
Euphorbia
ingens
Maceration
(methanol)
Active at 1 g/ml (MIC not
determined)
Not tested
IC50 = 105.55
Phenols, terpenoids
[28]
Euphorbia
scarlatica
Soxhlet (methanol) < 500 (Iso < 500)
Not tested
Not tested
Alkaloids, cardiac
glycosides, terpenoids,
flavonoids
[29]
Gnidia
buchananii
Maceration
(methanol)
Active at 1 g/ml (MIC not
determined)
Not tested
IC50 = 76.24
Phenols, terpenoids,
[28]
Indigofera
lupatana
Maceration
(methanol)
Not active
Not tested
IC50 = 60.37
Phenols, terpenoids
[28]
Khaya
senegalensis
Maceration (ethyl
acetate,
chloroform)
6.25
Not tested
IC50 = 1000
Not tested
[52]
Obakiro et al. Tropical Medicine and Health
Page 15 of 21
(2020) 48:68
Table 2 Efficacy, toxicity, and phytochemical studies on medicinal plants used for treatment of TB in East Africa (Continued)
Plant
Extraction method MIC (μg/ml) on
(solvent)
H37Rv strain
MIC (μg/ml) on
TMC-331 strain
Toxicity of crude
extracts (μg/ml)
Class of compounds
Author(s)
Lantana
camara
Maceration
(methanol,
chloroform)
20 (Rif = 1)
15 (Iso = 0.25)
LD50 > 500 mg/
kg
Not reported
[53]
Lonchocarpus
eriocalyx
Maceration
(methanol)
Not active
Not tested
IC50 = 201.87
Terpenoids, phenols,
flavonoids
[28]
Loranthus
acaciae
Soxhlet (methanol) < 1000 (Iso < 500)
Not tested
Not tested
Alkaloids, cardiac
glycosides, saponins,
flavonoids
[29]
Mangifera
indica
Methanol
3130 (methanol) (Iso = 0.25; R
= 0.25)
590 (methanol) (Iso
= 0.25)
Not tested
Phenols, terpenoids
[16]
Pentos
longiflora
Maceration
(ethanol)
1000
Not tested
Not tested
Not tested
[37]
Piptadenistrum
africana
Maceration
(chloroform)
395 (chloroform)
395 (chloroform)
Not tested
Flavonoids, tannins
[15]
Plumbago
dawei
Soxhlet (methanol) < 1000 (Iso < 500)
Not tested
Not tested
Cardiac glycosides,
tannins, terpenoids,
flavonoids
[29]
Rosmarinus
officinalis L.
Maceration
(chloroform)
Not tested
IC50 = 100
Not tested
[52]
Salvadora
persica
Soxhlet (methanol) < 500 (Iso < 500)
Not tested
Not tested
Alkaloids, cardiac
glycosides, terpenoids,
flavonoids
[29]
Solanum
incanum
Methanol
chloroform
Not active
Not active
Not tested
Not reported
[16]
Tetradenia
riparia
Maceration
(ethanol)
500
Not tested
Not tested
Not tested
[37]
Warburgia
ugandensis
Methanol
chloroform
4690 (methanol), 2350
(chloroform) (Iso = 0.25; R =
0.25)
2350 (methanol),
590 (chloroform)
(Iso = 0.25)
Not tested
Flavonoids, tannins,
terpenoids
[85, 86]
Zanthoxylum
leprieurii
Methanol
47.5 (Iso = 4.0; R = 2.0)
75.3 (Iso = 4.0)
Not tested
Alkaloids
[5]
6.25
IC50 median cytotoxic concentration, LD50 median lethal dose, Iso isoniazid, Rif rifampicin, H37Rv pan sensitive Mtb strain, TMC331 rifampicin-resistant Mtb strain,
MIC minimum inhibitory concentration. Extracts in [26] were tested against Mycobacteria smegmatis
calculated (Table 4) because they were the only plant
species with both the inhibitory concentration on Mtb
and cytotoxic concentration on normal mammalian cell
lines (IC50) reported. Hence, there is need to emphasize
dual testing of both toxicity and efficacy of natural products for drug development purposes.
Two other systems of acute toxicity classification: The
National Cancer Institute (NCI) and Organization for
Economic cooperation and development (OECD) guidelines 423 were used to assess the toxicity profiles of the
different extracts [89, 90]. There was no single plant species among those tested for acute toxicity that was reported to be highly toxic (with IC50 less than 20 μg/ml).
All the plant species with promising bioactivity that were
tested for toxicity had acceptable acute toxicity profiles.
These included Rosmarinus officinalis, Lantana camara,
Khaya senegalensis, and Erythrina abyssinica (Table 2).
Aspilia pluriseta, Cissampelos pareira, Euphorbia ingens,
and Gnidia buchananii had moderate toxicity with IC50
between 20 and 200 μg/ml. According to OECD 2001
Table 3 Isolation and characterization studies on medicinal plants used for management of TB in East Africa
Plant
Pure compounds with antitubercular activity
Zanthoxylum leprieurii
2-hydroxy-1, 3-dimethoxy-10-methyl-9-acridone (1), Acridone alkaloids 1.5 (1), 0.2 (2), 0.4 (3);
tested against H37Rv
1-hydroxy-3-methoxy-10-methyl-9-acridone (2),
3-hydroxy-1, 5, 6-trimethoxy-9-acridone (3)
Chemical class
MIC of pure compounds (μg/ml) Author(s)
[5]
Warburgia ugandensis Sprague Muzigadial (4), muzigadiolide (5), linoleic acid (6)
Sesquiterpenes
64 (4), 128 (5), 16 (6);
tested against M. smegmatis
[58, 85]
Tetradenia riparia
Diterpenediol
25–100
[37]
15- sandaracopimaradiene-7α, 18-dio1 (7)
MIC minimum inhibitory concentration. No toxicity studies of the pure compounds were conducted.
Obakiro et al. Tropical Medicine and Health
Page 16 of 21
(2020) 48:68
Table 4 Selectivity indices of some antitubercular plant species reported in East Africa
Plant
Solvent
MIC on Mtb strain (μg/
ml)
Commiphora edulis
Dichloromethane 1560
IC50 (μg/
ml)
SI
Comment
393
0.25
More toxic to human cells than the Mtb; not useful
Ethyl acetate
3125
1734
0.55
More toxic to human cells than the Mtb; not useful
Water
780
1509
1.93
More toxic to Mtb than human cells but the SI is low.
May be optimized for lead candidate identification
Methanol
3125
608
0.19
More toxic to human cells than the Mtb; not useful
Methanol
390
452
1.16
More toxic to Mtb than human cells but the SI is close
to 1. No practical application
Ethyl acetate
6250
339
0.054 More toxic to human cells than the Mtb; not very useful
Khaya senegalensis
Chloroform
6.25
1000
160
More toxic to Mtb than human cells with high SI. Promising
for development of lead candidate
Rosmarinus officinalis
L.
Chloroform
6.25
100
16
More toxic to Mtb than human cells with high SI. Promising
for development of lead candidate
Commiphora
ellenbeckii
Commiphora
mildbraedii
IC50 cytotoxic concentration normal cells, SI selectivity index
guidelines, Lantana camara, Erythrina abyssinica, and
Cryptolepis sanguinolenta had slight toxicity as their median lethal doses (LD50) were above 500 mg/kg. These
results justify the general public belief that traditional
medicines are relatively safer as compared to the current
conventional therapies. However, toxicity testing should
be done on all potential medicinal plants and their phytochemicals before concluding that they are safe for human treatment [91–94]. This is because toxicity of
herbal medicines may be due to presence of inherent
poisonous chemicals in the plant species, misidentification of the plant species, adulteration or contamination
during harvesting, preparation, and storage [95, 96].
Acute toxicity tests determine a single high dose that
kills 50% of the cells or animals in a population. They
may not be evident enough to depict the real toxicity
situation for herbal remedies taken for a longer time in
chronic conditions like TB [18, 97]. Therefore, this may
necessitate sub-chronic and chronic toxicity tests to be
carried out on a medicinal plant species with a potential
lead compound [95].
Phytochemistry of the reported plants
Phytochemical investigation reveals the chemical nature
of the pure compounds that are responsible for the
pharmacological activity as well as the toxicity of medicinal plants [19, 64, 98–101]. Chromatographic and
spectroscopic techniques are used to identify and elucidate the chemical structures of compounds [102–107].
In this study, maceration was the commonly used
method of extraction as compared to Soxhlet. Majority
of the hexane extracts were reported to be inactive
against mycobacterial strains while almost all methanolic
extracts were active. Methanol being a polar solvent extracts polar phytochemical while hexane (a non-polar
solvent) extracts non-polar compounds. It is reasonable
to assert that the antimycobacterial activity of the
extracts is largely due to polar phytochemicals. There
were variations in bioactivity of different parts of the
same plant with no specific patterns. This could be due
to differences in their rate of accumulating the bioactive
substances.
The phytochemicals that were frequently screened for
have been alkaloids, saponins, cardiac glycosides, flavonoids, terpenoids, and phenols. All these secondary metabolites were reported to be present in different
bioactive extracts. The most commonly reported phytochemicals were flavonoids, terpenoids, and alkaloids [15,
17, 26, 29, 70, 106, 108]. Flavonoids and alkaloids were
reported to be absent in three out of the five inactive
plants (Table 2). Out of the 31 bioactive plant species,
only three (Tetradenia riparia, Warburgia ugandensis,
and Zanthoxylum leprieurii) have been further characterized to identify the pure compounds responsible for
their antimycobacterial activity [5, 37, 58, 85] (Table 3).
This is attributed to the complexity and the rigorous nature of the process that require extraction, screening,
isolation, and characterization [100, 109, 110]. Low extraction yield, compound instability, high costs, low
technology especially in developing countries, limited access to advanced chromatographic, and spectroscopic
equipment and inadequate funding have made it difficult
to undertake herbal medicine research [21, 111, 112].
This is further complicated by the microbiological nature of the Mtb that require bioassays to be conducted
in biosafety level 3 laboratories that are not readily available in East Africa [60, 113]. More robust and effective
techniques are required to fasten the drug discovery
process against TB [3, 77, 92, 114].
A total of seven pure compounds have been isolated
and characterized with bioactivity against Mtb (Fig. 5).
These are 2-hydroxy-1,3-dimethoxy-10-methyl-9-acridone (1), 1-hydroxy-3- methoxy-10-methyl-9-acridone
(2), 3-hydroxy-1, 5, 6-trimethoxy-9-acridone (3),
Obakiro et al. Tropical Medicine and Health
(2020) 48:68
Page 17 of 21
Fig. 5 Structure of antitubercular molecules isolated in claimed medicinal plants in East Africa. The numbers 1–7 correspond to the molecules
mentioned in Table 3
muzigadial (4), muzigadiolide (5), linoleic acid (6), and
15-sandaracopimaradiene-7α, 18-dio1 (7). Compounds
1, 2, and 3 are acridone alkaloids; 4, 5, and 6 are sesquiterpenes, while 7 is a diterpenediol [5, 37, 85]. In Asia
and America, several studies have reported pure compounds isolated from medicinal plants to have promising
antimycobacterial activity [78, 115–117]. For example,
Bisbenzylisoquinoline alkaloids from Tiliacora triandra
(tiliacorinine, tiliacorine and 2′-nortiliacorinine) were
found to have comparable antimycobacterial activity
(MIC = 0.7–6.2 μg/ml) to the standard first line drugs
against sensitive and resistant Mtb strains [108]. Rukachaisirikul et al. [118] reported that 5- hydroxysophoranone (an isoflavone from Erythrina stricta) had
promising antimycobacterial activity (MIC = 12.5 μg/ml)
against Mtb H37Ra. Vasicine acetate and 2-acetyl benzylamine isolated from hexane extract of Adhatoda vasica
Ness. (Acanthaceae) inhibited one sensitive and
multidrug-resistant strain at 50 and 200 μg/ml respectively [119]. Since flavonoids and alkaloids were reported
to be absent in three out of the five inactive plants [28]
and majority of the isolated bioactive pure compounds
belong to the class of alkaloids, terpenoids, and flavonoids [5, 85, 118], it implies that these classes of phytochemicals are the ones most likely to be responsible for
the observed antimycobacterial activity.
Conclusion
East Africa has a rich diversity of medicinal plants that
have been reported to be effective in the management of
symptoms of TB. Most of the plants are from the family
Fabaceae, Lamiaceae, and Asteraceae. A large proportion
of the documented plants have not been scientifically
validated for their efficacy and safety. Although the
standard drugs had superior activity, majority of the validated plants were found to possess acceptable acute toxicity profile on animal cells and considerable bioactivity
with isolated pure compounds showing promising efficacy against Mtb. We recommend more scientific validation studies to be conducted on the remaining plants in
order to standardize herbal medicine use and also promote drug discovery and development against TB. More
Obakiro et al. Tropical Medicine and Health
Page 18 of 21
(2020) 48:68
isolation and characterization studies will enrich the
chemical diversity of both the natural product and synthetic chemical libraries from which possible lead candidates could be developed. Currently, we are working on
isolation and characterization of bioactive compounds
from selected medicinal plants from family Fabaceae
identified from this study. These include Erythrina abyssinica, Albizia coriaria, and Entada abyssinica.
Supplementary information
Supplementary information accompanies this paper at https://doi.org/10.
1186/s41182-020-00256-1.
Additional file 1: Figure S1. PRISMA flow diagram used for the review.
Abbreviations
IC50: Median cytotoxic concentration; LD50: Median lethal dose; Iso: Isoniazid;
MIC: Minimum inhibitory concentration; Rif: Rifampicin; H37Rv: Pan sensitive
Mtb strain; TMC331: Rifampicin-resistant Mtb strain; SI: Selectivity Index;
TB: Tuberculosis; WHO: World Health Organization
Acknowledgements
The authors are grateful to the World Bank and the Inter-University Council
of East Africa (IUCEA) for the scholarship awarded to SBO, MPO, and TO
through the Africa Centre of Excellence II in Phytochemicals, Textiles and Renewable Energy (ACE II PTRE) at Moi University, Kenya, which made this communication possible. The authors commend preceding authors for their
fruitful quest for knowledge on medicinal plants utilized by rural communities of East Africa, the reports of which the current study was based.
Authors’ contributions
SBO, AK, IK, EK, MPO, TO, and LB designed the study. SBO, IK, EK, MPO, TO,
and LB performed literature search for medicinal plants in Uganda, Burundi,
Rwanda, Kenya, Tanzania, and South Sudan, respectively. SBO and TO
analyzed the collected data. TO, MPO, and LB verified the plant names in
botanical databases and local languages. SBO, MPO, TO, and LB wrote the
first draft of the manuscript. AK, IK, and EK reviewed the draft manuscript. All
authors revised and approved the final manuscript.
Funding
This research received no external funding.
Availability of data and materials
This is a review article and no raw experimental data were collected. All data
generated or analyzed during this study are included in this published
article.
Ethics approval and consent to participate
Not applicable
Consent for publication
Not applicable
Competing interests
The authors declare that there is no conflict of interest regarding the
publication of this paper.
Author details
1
Department of Pharmacology and Therapeutics, Faculty of Health Sciences,
Busitema University, P.O. Box 1460, Mbale, Uganda. 2Department of
Chemistry and Biochemistry, School of Sciences and Aerospace Studies, Moi
University, P.O. Box 3900-30100, Eldoret, Kenya. 3Africa Centre of Excellence II
in Phytochemicals, Textiles and Renewable Energy (ACE II PTRE), Moi
University, P.O. Box 3900-30100, Eldoret, Kenya. 4Department of Pure and
Applied Chemistry, Faculty of Science, Masinde-Muliro University of Science
and Technology, P.O. Box 190-50100, Kakamega, Kenya. 5Centre of Traditional
Medicine and Drug Research, Kenya Medical Research Institute, P.O. Box
54840-00200, Nairobi, Kenya. 6Department of Quality Control and Quality
Assurance, Product Development Directory, AgroWays Uganda Limited, Plot
34-60, Kyabazinga Way, P.O. Box 1924, Jinja, Uganda. 7Department of
Pharmacology and Therapeutics, School of Biomedical Sciences, Makerere
University College of Health Sciences, P.O. Box 7062, Kampala, Uganda.
Received: 27 April 2020 Accepted: 4 August 2020
References
1. WHO. Global Tuberculosis Report 2019. World Health Organization, Geneva,
Switzerland. 2019. 297p. https://apps.who.int/iris/bitstream/handle/10665/32
9368/9789241565714-eng.pdf?ua=1. Acessed 04 March 2020.
2. Hiraiwa M, Kim J, Lee H, Inoue S, Becker AL, Weigel KM, et al. Amperometric
immunosensor for rapid detection of Mycobacterium tuberculosis. J
Micromech Microeng. 2015;25:055013.
3. Yuan T, Sampson NS. Hit generation in TB drug discovery: from genome to
granuloma. Chem Rev. 2018;118:1887–916.
4. Ambrosio LD, Centis R, Sotgiu G, Pontali E, Spanevello A, Migliori GB. New
anti-tuberculosis drugs and regimens: 2015 update. ERJ Open Res. 2015;1:
00010–2015.
5. Bunalema L, Fotso GW, Waako P, Tabuti J, Yeboah SO. Potential of
Zanthoxylum leprieurii as a source of active compounds against drug
resistant Mycobacterium tuberculosis. BMC Complement Altern Med. 2017;17:
89.
6. Godebo A, Abiy H, Toma A. Recent advances in the development of antituberculosis drugs acting on multidrug-resistant strains: a review. Int J Res
Pharm Biosci. 2015;2:1–18.
7. Bunalema L, Obakiro S, Tabuti JRS, Waako P. Knowledge on plants used
traditionally in the treatment of tuberculosis in Uganda. J Ethnopharmacol.
2014;151:999–1004.
8. Schultz F, Anywar G, Wack B, Quave CL, Garbe L. Ethnobotanical study of
selected medicinal plants traditionally used in the rural greater Mpigi region
of Uganda. J Ethnopharmacol. 2020;256:112742.
9. Tugume P, Kakudidi EK, Buyinza M, Namaalwa J, Kamatenesi M, Mucunguzi
P, et al. Ethnobotanical survey of medicinal plant species used by
communities around Mabira central Forest reserve, Uganda. J Ethnobiol
Ethnomed. 2016;12:5.
10. Tabuti JRS, Kukunda CB, Waako PJ. Medicinal plants used by traditional
medicine practitioners in the treatment of tuberculosis and related ailments
in Uganda. J Ethnopharmacol. 2010;127:130–6.
11. Jeruto P, Lukhoba C, Ouma G, Otieno D, Mutai C. An ethnobotanical study
of medicinal plants used by the Nandi people in Kenya. J Ethnopharmacol.
2008;116:370–6.
12. Orodho JA, Kirimuhuzya C, Otieno JN, Magadula JJ, Okemo P. Local
management of tuberculosis by traditional medicine practitioners in Lake
Victoria region. Open Complement Med J. 2011;3:1–9.
13. Anywar G, Kaduidi E, Byamukama R, Mukonzo J, Schubert A, Oryem-Origa H.
Indigenous traditional knowledge of medicinal plants used by herbalists in
treating opportunistic infections among people living with HIV/AIDS in
Uganda. J Ethnopharmacol. 2020;246:112205.
14. WHO Global Report on Traditional and Complementary Medicine. 2019.
https://www.who.int/traditional-complementary-integrative-medicine/
WhoGlobalReportOnTraditionalAndComplementaryMedicine2019.pdf?ua=1.
Accessed 04 March 2020.
15. Bunalema L, Tabuti J, Sekagya Y, Ogwang S, Waako P. Anti-tubercular
activity of Callistemon citrinus and Piptadenistrum africanum on resistant
strains of Mycobacterium tuberculosis using microplate alamar blue assay.
Spat DD. 2015;5:235–40.
16. Magadula JJ, Otieno JN, Nondo RS, Kirimuhuzya C, Kadukuli E, Orodho JA,
et al. Eur J Med Plants. 2012;2:125–31.
17. Mariita M. Efficacy of medicinal plants used by communities around Lake
Victoria region and the Samburu against mycobacteria, selected bacteria
and Candida albicans. Nairobi: Kenyatta University; 2011.
18. Obakiro SB, Bunalema L, Nyatia E, Waako JP. Ulcerogenic potential of
Eucalyptus globulus L. leaf extract in Wistar albino rats. J Pharmacol Toxicol.
2018;4:46–51.
19. Omara T. Plants ised in antivenom therapy in rural Kenya: ethnobotany and
future perspectives. J Toxicol. 2020;2020:1–9. https://doi.org/10.1155/2020/
1828521.
Obakiro et al. Tropical Medicine and Health
(2020) 48:68
20. Alamgeer, Younis W, Asif H, Sharif A, Riaz H, Bukhari IA, et al. Traditional
medicinal plants used for respiratory disorders in Pakistan: a review of the
ethno-medicinal and pharmacological evidence. Chin Med. 2018;13:48.
21. Zuniga ES, Early J, Parish T. The future for early-stage tuberculosis drug
discovery. Future Microbiol. 2015;10:217–29.
22. Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group. Preferred
reporting items for systematic reviews and meta-analyses: the PRISMA
statement. PLoS Med. 2009;6:e1000097.
23. Omara T, Kagoya S, Openy A, Omute T, Ssebulime S, Kiplagat KM, et al.
Antivenin plants used for treatment of snakebites in Uganda:
ethnobotanical reports and pharmacological evidences. Trop Med Health.
2020;48:6.
24. Omara T, Kiprop AK, Ramkat RC, Cherutoi J, Kagoya S, Nyangena DM, et al.
Medicinal plants used in traditional management of cancer in Uganda: a
review of ethnobotanical surveys, phytochemistry, and anticancer studies.
Evidence-Based Complement Alternat Med. 2020;2020:1–26. https://doi.org/
10.1155/2020/3529081.
25. Omara T. Antimalarial plants used across Kenyan communities. EvidenceBased Complement Alternat Med. 2020;2020:1–31. https://doi.org/10.1155/
2020/4538602.
26. Nimbeshaho F, Mwangi CN, Orina F, Chacha M, Moody JO, Kigondu EM.
Antimycobacterial activities, cytotoxicity and phytochemical screening of
extracts for three medicinal plants growing in Kenya. J Med Plants Res.
2020; (in press).
27. Ayaz M, Ullah F, Sadiq A, Ullah F, Ovais M, Ahmed J, et al. Interactions
synergistic interactions of phytochemicals with antimicrobial agents :
potential strategy to counteract drug resistance. Chem Biol Interact. 2019;
308:294–303.
28. Njeru SN, Obonyo MA. Potency of extracts of selected plant species from
Mbeere, Embu County-Kenya against Mycobacterium tuberculosis. J Med
Plant Res. 2016;10:149–57.
29. Mariita RM, Ogol CKPO, Oguge NO, Okemo PO. Antitubercular and
phytochemical investigation of methanol extracts of medicinal plants used
by the Samburu community in Kenya. Trop J Pharm Res. 2010;9:379–85.
30. Musa MS, Abdelrasool FE, Elsheikh EA, Ahmed LAMN, Mahmoud ALE, Yagi
SM. Ethnobotanical study of medicinal plants in the Blue Nile state, SouthEastern Sudan. J Med Plant Res. 2011;5:287–4297.
31. Kimathi KN, Ogutu PA, Mutai C, Jeruto P. Ethnobotanical study of selected
medicinal plants used against bacterial infections in Nandi county. Kenya.
2019;7:103–8.
32. Watt JM, Breyer-Brandwijk G. Medicinal and poisonous plants of southern
and eastern Africa. 2nd ed. Edinburgh & London: E. & S. Livingstone Ltd;
1962. 394p.
33. Shiracko N, Owuor BO, Gakuubi MM, Wanzala W. A survey of ethnobotany
of the AbaWanga people in Kakamega county, Western province of Kenya.
Indian J Tradit Knowle. 2016;15:93–102.
34. Fratkin E. Traditional medicine and concepts of healing among samburu
pastoralists of Kenya. J Ethnobiol. 1996;16:63–97.
35. Ghazali GE, Abdalla WE, El H, Khalid S, Khalafalla M. Medicinal plants of Sudan,
part V: medicinal plants of Ingassana area. Khartoum, Sudan: National Center
for Research, Ministry of Science and Technology; 2003. p. 1–19.
36. Okello SV, Nyunja RO, Netondo GW, Onyango JC. Ethnobotanical study of
medicinal plants used by sabaots of Mt. Elgon Kenya. Afr J Tradit
Complement Altern Med. 2010;7:1–10.
37. Van Puyvelde L, Ntawukiliyayo JD, Portaels F, Hakizamungu E. In vitro
inhibition of mycobacteria by Rwandese medicinal plants. Phytother Res.
1994;8:65–9.
38. Ngezahayo J, Havyarimana F, Hari L, Stévigny C, Duez P. Medicinal plants
used by Burundian traditional healers for the treatment of microbial
diseases. J Ethnopharmacol. 2015;173:338–51.
39. Gafna DJ, Dolos K, Mahiri IO, Mahiri JG, Obando JA. Diversity of medicinal
plants and anthropogenic threats in the Samburu central sub-county of
Kenya. Afr J Tradit Complement Altern Med. 2017;14:72–9.
40. Kiringe JW. A survey of traditional health remedies used by the Maasai of
southern Kaijiado district, Kenya. Ethnobot Res Appl. 2006;4:61–73.
41. Kokwaro JO. Medicinal plants of East Africa. 3rd ed. Nairobi: East Africa
Literature Bureau; 1976.
42. El-Kamalia HH, El-Khalifa KF. Folk medicinal plants of riverside forests of the
southern Blue Nile district, Sudan. Fitoterapia. 1999;70:493–7.
43. Burham BO. Chemical constituents of selected Sudanese medicinal and
aromatic plants; 2007.
Page 19 of 21
44. Bunalema L, Kirimuhuzya C, Tabuti JRS, Waako P, Magadula JJ, Otieno
N, et al. The efficacy of the crude root bark extracts of Erythrina
abyssinica on rifampicin resistant mycobacterium tuberculosis. Afr
Health Sci. 2011;11:587–93.
45. Desouter S. Human and veterinary pharmacopoeia, vol. 22. Tervuren; 1991.
p. 252.
46. Amuka O, Okemo PO, Alex K, Mbugua PK. Ethnobotanical survey of selected
medicinal plants used by Ogiek communities in Kenya against microbial
infections. Ethnobot Res Appl. 2014;12:627–41.
47. Orodho JA, Okemo P, Tabuti JB, Otieno N, Magadula JJ, Kirimuhuzya C.
Indigenous knowledge of communities around Lake Victoria Basin
regarding treatment and management of tuberculosis using medicinal
plants. Int J Med Sci. 2014;6:16–23.
48. Kayonga A, Habiyaremye FX. Traditional medicine and Rwandan medicinal
plants. Contribution to ethnobotanic study of Rwandan Flora. Gisenyi
prefecture. Curfametra: Univ. Nat. University Research Center on
pharmacopoeia and traditional medicine; 1987. p. 121.
49. Sospeter NN, Meshack AO. Potency of extracts of selected plant species
from Mbeere, Embu County-Kenya against Mycobacterium tuberculosis. J
Med Plants Res. 2016;10:149–57.
50. Cyrus WG, Daniel GW, Nanyingi MO, Njonge FK, Mbaria JM. Antibacterial
and cytotoxic activity of Kenyan medicinal plants. Mem Inst Oswaldo Cruz.
2008;103:650–2.
51. Nanyingi MO, Mbaria JM, Lanyasunya AL, Wagate CG, Koros KB, Kaburia HF,
et al. Ethnopharmacological survey of Samburu district, Kenya. J Ethnobiol
Ethnomed. 2008;12:1–12.
52. Abuzeid N, Kalsum S, Larsson M, Glader M, Andersson H, Raffetseder J, et al.
Antimycobacterial activity of selected medicinal plants traditionally used in
Sudan to treat infectious diseases. J Ethnopharmacol. 2014;157:134–9.
53. Kirimuhuzya C, Waako P, Joloba M, Odyek O. The anti-mycobacterial activity
of Lantana camara a plant traditionally used to treat symptoms of
tuberculosis in South-Western Uganda. Afr Health Sci. 2009;9:40–5.
54. EL-Kamali HH. Ethnopharmacology of medicinal plants used in North
Kordofan (Western Sudan). Ethnobot Leaf. 2009;13:203–10.
55. Nankaya J, Nampushi J, Petenya S, Balslev H. Ethnomedicinal plants of the
Loita Maasai of Kenya. Environ Dev Sustain. 2019. https://doi.org/10.1007/
s10668-019-00311-w.
56. Nankaya J, Gichuki N, Lukhoba C, Balslev H. Medicinal plants of the Maasai
of Kenya: a review. Plants. 2020;9:1–17.
57. Asiimwe S, Kamatenesi-Mugisha M, Namutebi A, Borg-Karlsson AK,
Musiimenta P. Ethnobotanical study of nutri-medicinal plants used for the
management of HIV/AIDS opportunistic ailments among the local
communities of western Uganda. J Ethnopharmacol. 2013;150:639–48.
58. Mbwambo Z, Erasto P, Innocent E, Masimba P. Antimicrobial and cytotoxic
activities of fresh leaf extracts of Warburgia ugandensis. Tanzan J Health Res.
2009;11:75–8.
59. Okello D, Kang Y. Ethnopharmacological potentials of Warburgia ugandensis
on antimicrobial activities. Chin J Integr Med. 2019. https://doi.org/10.1007/
s11655-019-3042-6.
60. Buwa LV, Afolayan AJ. Antimicrobial activity of some medicinal plants used
for the treatment of tuberculosis in the eastern Cape Province, South Africa.
Afr J Biotechnol. 2009;8:6683–7.
61. Babalola IT, Adelakun EA. Compendium of medicinal plants for the ethnotherapeutic management of tuberculosis and other respiratory diseases. J
Pharmacog Phytochem. 2018;7:1983–94.
62. Semenya SS, Maroyi A. Medicinal plants used for the treatment of
tuberculosis by Bapedi traditional healers in three districts of the Limpopo
province, South Africa. Afr J Tradit Complement Altern Med. 2012;10:316–23.
63. Alvin A, Miller KI, Neilan BA. Exploring the potential of endophytes from
medicinal plants as sources of antimycobacterial compounds. Microbiol Res.
2014;169:483–95.
64. Semenya SS, Maroyi A. Ethnobotanical survey of plants used by Bapedi
traditional healers to treat tuberculosis and its opportunistic infections in
the Limpopo Province, South Africa. South Afr J Bot. 2019;122:401–21.
65. Green E, Samie A, Obi CL, Bessong PO, Ndip RN. Inhibitory properties of
selected south African medicinal plants against Mycobacterium tuberculosis.
J Ethnopharmacol. 2010;130:151–7.
66. Famewo EB, Clarke AM, Wiid I, Ngwane A, Van Helden P, Afolayan AJ. Antimycobacterium tuberculosis activity of polyherbal medicines used for the
treatment of tuberculosis in eastern cape, South Africa. Afr Health Sci. 2017;
17:780–9.
Obakiro et al. Tropical Medicine and Health
(2020) 48:68
67. Ibekwe NN, Ameh SJ. Plant natural products research in tuberculosis drug
discovery and development: a situation report with focus on Nigerian
biodiversity. Afr J Biotechnol. 2014;13:2307–20.
68. Mann A, Amupitan JO, Oyewale AO, Okogun JI, Ibrahim K, Oladosu P, et al.
Evaluation of in vitro antimycobacterial activity of Nigerian plants used for
treatment of respiratory diseases. Afr J Biotechnol. 2008;7:1630–6.
69. Nguta JM, Appiah-Opong R, Nyarko AK, Yeboah-manu D, Addo PGA, KissiTwum A. Antimycobacterial and cytotoxic activity of selected medicinal
plant extracts. J Ethnopharmacol. 2016;182:10–5.
70. Gemechu A, Giday M, Worku A, Ameni G. In vitro anti-mycobacterial activity
of selected medicinal plants against Mycobacterium tuberculosis and
Mycobacterium bovis strains. BMC Complement Altern Med. 2013;13:291.
71. Pandit R, Singh PK, Kumar V. Natural remedies against multi-drug resistant
Mycobacterium tuberculosis. J Tuberculosis Res. 2015;3:171–83.
72. Rai R. Herbal remedies in cure of tuberculosis prevalent among ethnic
communities in Central India. Trop Plant Res. 2016;3:344–53.
73. Mongalo NI, McGaw LJ, Segapelo TV, Finnie JF, Van Staden J. Ethnobotany,
phytochemistry, toxicology and pharmacological properties of Terminalia sericea
Burch. Ex DC. (Combretaceae) – a review. J Ethnopharmacol. 2016;94:789–802.
74. Saleh-e-In MM, Van Staden J. Ethnobotany, phytochemistry and
pharmacology of Arctotis arctotoides (L.f.) O. Hoffm.: a review. J
Ethnopharmacol. 2018;220:294–320.
75. Sharma A, Flores-Vallejo RC, Cardoso-Taketa A, Villarreal ML. Antibacterial
activities of medicinal plants used in Mexican traditional medicine. J
Ethnopharmacol. 2017;208:264–329.
76. Ngadino S, Koerniasari E, Sudjarwo SA. Evaluation of antimycobacterial
activity of Curcuma xanthorrhiza ethanolic extract against Mycobacterium
tuberculosis H37Rv in vitro. Vet World. 2018;11:368–72.
77. Tuyiringire N, Tusubira D, Munyampundu JP, Tolo CU, Muvunyi CM,
Ogwang PE. Application of metabolomics to drug discovery and
understanding the mechanisms of action of medicinal plants with antituberculosis activity. Clin Transl Med. 2018;7:29.
78. Al-baadani WA, Satyanarayan ND. Anti-tubercular evaluation of Rivea
hypocrateriformis (Der.) choisy against Mycobacterium tuberculosis H37Rv
strain. J Pharmacognosy Phytochem. 2018;7:2679–82.
79. Lawal IO, Grierson DS, Afolayan AJ. Phytotherapeutic information on plants
used for the treatment of tuberculosis in eastern Cape Province. South
Africa Evidence-based Complement Altern Med. 2014:1–11. https://doi.org/
10.1155/2014/735423.
80. Nguta JM, Appiah-Opong R, Nyarko AK, Yeboah-Manu D, Addo PGA. Medicinal
plants used to treat TB in Ghana. Int J Mycobacteriol. 2015;4:116–23.
81. Ogbole OO, Ajaiyeoba EO. Traditional management of tuberculosis in Ogun
state of Nigeria: the practice and ethnobotanical survey. Afr J Tradit
Complement Altern Med. 2010;7:79–84.
82. Stewart ZP, Pierzynski GM, Middendorf BJ, Prasad PVV. Approaches to
improve soil fertility in sub-Saharan Africa. J Exp Bot. 2020;71:632–41.
83. Ge F, Zheng F, Liu S, Guo N, Ye H, Song Y, et al. In vitro synergistic
interactions of oleanolic acid in combination with isoniazid, rifampicin
or ethambutol against Mycobacterium tuberculosis. J Med Microbiol.
2010;59:567–72.
84. Kirimuhuzya C. Efficacy of Cryptolepis sanguinolenta root extract on slowgrowing rifampicin resistant Mycobacterium tuberculosis. J Med Plants Res.
2012;6:1140–6.
85. Wube AA, Bucar F, Gibbons S, Asres K. Sesquiterpenes from Warburgia
ugandensis and their antimycobacterial activity. Phytochem. 2005;66:
2309–15.
86. Kirimuhuzya C, Bunalema L, Tabuti JRS, Kakudidi EK, Orodho J, Magadula J,
et al. The in vitro antimycobacterial activity of medicinal plants used by
traditional medicine practitioners (TMPs) to treat tuberculosis in the Lake
Victoria basin in Uganda. In: A presentation at the 14th NAPRECA
symposium held at ICIPE, Kasarani, Nairobi, Kenya; 2011.
87. Gautam R, Saklani A, Jachak SM. Indian medicinal plants as a source of
antimycobacterial agents. J Ethnopharmacol. 2007;110:200–34.
88. Kaminsky R, Caecilia S, Reto B. An “in vitro selectivity index” for evaluation of
cytotoxicity of antitrypanosomal compounds. In vitro Toxicol. 1996;9:315–24.
89. OECD. OECD guideline for testing of chemicals: acute oral toxicity – acute
toxic class method. OECD Guideline for Testing of Chemicals, no.
December: 1–14. 2001. doi: https://doi.org/10.1787/9789264070943-en.
90. Geran RI, Greenberg HM, McDonald M, Abbott BJ. Protocols for screening
chemical agents and natural products against animal tumors and other
biological systems. Cancer Chemoth Rep. 1972;33:1–17.
Page 20 of 21
91. Keter L, Too R, Mwikwabe N, Mutai C, Orwa J, Mwamburi L, et al. Risk of
fungi associated with aflatoxin and fumonisin in medicinal herbal products
in the Kenyan market. Sci World J. 2017;1892972.
92. Pan S, Zhou S, Gao S, Yu Z, Zhang S, Tang M, et al. “New perspectives on
how to discover drugs from herbal medicines: CAM’s outstanding
contribution to modern therapeutics. Evidence-based complement. Altern
Med. 2013. https://doi.org/10.1155/2013/627375.
93. Ko RJ. A U.S. perspective on the adverse reactions from traditional Chinese
medicines. J Chin Med Assoc. 2004;67:109–16.
94. Chuluun B, Iamchaturapatr J, Rhee J. Phytoremediation of
organophosphorus and organochlorine pesticides by Acorus gramineus.
Environ Eng Res. 2009;14:226–36.
95. Ekor M. The growing use of herbal medicines: issues relating to adverse
reactions and challenges in monitoring safety. Front Pharmacol. 2014;4:177.
96. Tomlinson B, Chan TY, Chan JC, Critchley JA, But PP. Toxicity of
complementary therapies: an eastern perspective. J Clin Pharmacol. 2000;40:
451–6.
97. Aniagu S, Nwinyi F, Akumka DD, Ajoku GD, Dzarma S, Izebe KS. Toxicity
studies in rats fed nature cure bitters. Afri J Biotechnol. 2005;4:72–8.
98. Agyare C, Boakye YD, Bekoe EO, Hensel A, Dapaah SO, Appiah T. Review:
African medicinal plants with wound healing properties. J Ethnopharmacol.
2016;177:85–100.
99. Owor RO, Bedane KG, Zühlke S, Derese S, Ong'amo GO, Ndakala A, et al.
Anti-inflammatory flavanones and flavones from Tephrosia linearis. J Nat
Prod. 2020. https://doi.org/10.1021/acs.jnatprod.9b0092.
100. Gavamukulya Y, Maina EN, Meroka A, Madivoli ES, El-Shemy HA, Magom G,
et al. Liquid chromatography single quadrupole mass spectrometry (LC/SQ
MS) analysis reveals presence of novel antineoplastic metabolites in
ethanolic extracts of fruits and leaves of Annona muricata. Pharmacognosy
J. 2019;11:660–8.
101. Andima M, Coghi P, Yang LJ, Wong VKW, Ngule CM, Heydenreich M, et al.
Antiproliferative activity of secondary metabolites from Zanthoxylum
zanthoxyloides Lam : in vitro and in silico studies. Pharmacognosy Comm.
2020;10:44–51.
102. Bauer A, Brönstrup M. Industrial natural product chemistry for drug
discovery and development. Nat Prod Rep. 2014;31:35–60.
103. Saraswathi VS, Saravanan D, Santhakumar K. Isolation of quercetin from the
methanolic extract of Lagerstroemia speciosa by HPLC technique, its
cytotoxicity against MCF-7 cells and photocatalytic activity. J Photochem
Photobiol B. 2017;171:20–6.
104. Chraibi MM, Farah A, Lebrazi S, El Amine O, Iraqui Houssaini M, FikriBenbrahim K. Antimycobacterial natural products from Moroccan medicinal
plants: chemical composition, bacteriostatic and bactericidal profile of
Thymus satureioides and Mentha pulegium essential oils. Asian Pac J Trop
Biomed. 2016;6:836–40.
105. Hoerr V, Duggan GE, Zbytnuik L, Poon KKH, Große C, Neugebauer U, et al.
Characterization and prediction of the mechanism of action of antibiotics
through NMR metabolomics. BMC Microbiol. 2016;16:82.
106. Esquivel-ferriño PC, Favela-hernández JMJ, Garza-gonzález E, Waksman N,
Ríos MY, Camacho-corona MR. Antimycobacterial activity of constituents
from Foeniculum vulgare var. Dulce grown in Mexico. Molecules. 2012;17:
8471–82.
107. Zhao J, Evangelopoulos D, Bhakta S, Gray AI, Seidel V. Antitubercular activity
of Arctium lappa and Tussilago farfara extracts and constituents. J
Ethnopharmacol. 2014;155:796–800.
108. Sureram S, Senadeera SPD, Hongmanee P, Mahidol C, Ruchirawat S,
Kittakoop P. Antimycobacterial activity of bisbenzylisoquinoline alkaloids
from Tiliacora triandra against multidrug-resistant isolates of Mycobacterium
tuberculosis. Bioorg Med Chem Lett. 2012;22:2902–5.
109. Gao F, Ye L, Wang Y, Kong F, Zhao S, Xiao J. Benzofuran-isatin hybrids and
their in vitro anti-mycobacterial activities against multi-drug resistant
Mycobacterium tuberculosis. Eur J Med Chem. 2019;183:111678.
110. Machelart A, Song O, Hoffmann E, Brodin P. Host-directed therapies offer
novel opportunities for the fight against tuberculosis. Drug Discov Today.
2017;22:1250–7.
111. WHO. Global Tuberculosis Report 2017. WHO, Geneva, Switzerland. 2017.
262p. https://reliefweb.int/sites/reliefweb.int/files/resources/9789241565516eng.pdf. Accessed 4 Mar 2020.
112. Nguta JM, Appiah-Opong R, Nyarko AK, Yeboah-manu D, Addo PGA.
Current perspectives in drug discovery against tuberculosis from natural
products. Int J Mycobacteriol. 2017;4:165–83.
Obakiro et al. Tropical Medicine and Health
(2020) 48:68
113. Balouiri M, Sadiki M, Ibnsouda SK. Methods for in vitro evaluating
antimicrobial activity: a review. J Pharm Anal. 2016;6:71–9.
114. Manjunatha UH, Smith PW. Perspective: challenges and opportunities in TB drug
discovery from phenotypic screening. Bioorganic Med Chem. 2015;23:5087–97.
115. León-Díaz R, Meckes M, Said-Fernández S, Molina-Salinas GM, VargasVillarreal J, Torres J, et al. Antimycobacterial neolignans isolated from
Aristolochia taliscana. Mem Inst Oswaldo Cruz. 2010;105:45–51.
116. Bocanegra-Garcia V, Garcia A, Palma-Nicolás JP, Palos I, Rivera G.
Antitubercular drugs development: recent advances in selected therapeutic
targets and rational drug design. In: A case study based insight into
modern strategies. Intech open; 2011. p. 207–42.
117. Vyas DH, Tala SD, Dhaduk MF, Akbari JD, Joshi HS. Synthesis, antitubercular
and antimicrobial activities of some new pyrazoline and isoxazole
derivatives. J Indian Chem Soc. 2007;84:1140–4.
118. Rukachaisirikul T, Saekee A, Tharibun C, Watkuolham S. Biological activities
of the chemical constituents of Erythrina stricta and Erythrina subumbrans.
Arch Pharm Res. 2007;30:1398.
119. Ignacimuthu S, Shanmugam N. Antimycobacterial activity of two natural
alkaloids, vasicine acetate and 2-acetyl benzylamine, isolated from Indian
shrub Adhatoda vasica ness . Leaves. J Biosci. 2010;35:565–70.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Page 21 of 21